Inhibiting FLT3 signaling targets can ameliorate autoimmune disease
Wednesday, March 31st, 2010According to scientists at the Johns Hopkins Kimmel Cancer Center, treating autoimmune diseases such as multiple sclerosis can be possible now with a gene pathway linked to a deadly form of leukemia offering a new hope.
It was found by the scientists that in targeting an immune system cell often ignored in favor of T-cell targets [...]